Literature DB >> 16077034

Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function.

C L Parish1, J Nunan, D I Finkelstein, F N McNamara, J Y Wong, J L Waddington, R M Brown, A J Lawrence, M K Horne, J Drago.   

Abstract

Neuronal nicotinic acetylcholine receptors (nAChRs) at presynaptic sites can modulate dopaminergic synaptic transmission by regulating dopamine (DA) release and uptake. Dopaminergic transmission in nigrostriatal and mesolimbic pathways is vital for the coordination of movement and is associated with learning and behavioral reinforcement. We reported recently that the D2 DA receptor plays a central role in regulating the arbor size of substantia nigra dopaminergic neurons. Given the known effects of nAChRs on dopaminergic neurotransmission, we assessed the ability of the alpha4 nAChR subunit to regulate arbor size of dopaminergic neurons by comparing responses of wild-type and alpha4 nAChR subunit knockout [alpha4(-/-)] mice to long-term exposure to cocaine, amphetamine, nicotine, and haloperidol, and after substantia nigra neurotoxic lesioning. We found that dopaminergic neurons in adult drug-naive alpha4(-/-) mice had significantly larger terminal arbors, and despite normal short-term behavioral responses to drugs acting on pre- and postsynaptic D2 DA receptors, they were unable to modulate their terminal arbor in response to pharmacological manipulation or after lesioning. In addition, although synaptosome DA uptake studies showed that the interaction of the D2 DA receptor and the dopamine transporter (DAT) was preserved in alpha4(-/-) mice, DAT function was found to be impaired. These findings suggest that the alpha4 subunit of the nAChR is an independent regulator of terminal arbor size of nigrostriatal dopaminergic neurons and that reduced functionality of presynaptic DAT may contribute to this effect by impairing DA uptake.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077034     DOI: 10.1124/mol.104.004820

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Alterations of cortical pyramidal neurons in mice lacking high-affinity nicotinic receptors.

Authors:  Inmaculada Ballesteros-Yáñez; Ruth Benavides-Piccione; Jean-Pierre Bourgeois; Jean-Pierre Changeux; Javier DeFelipe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.

Authors:  Ryan M Drenan; Sharon R Grady; Andrew D Steele; Sheri McKinney; Natalie E Patzlaff; J Michael McIntosh; Michael J Marks; Julie M Miwa; Henry A Lester
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

Review 3.  Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.

Authors:  Christie D Fowler; Michael A Arends; Paul J Kenny
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

Review 4.  Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.

Authors:  George S Portugal; Thomas J Gould
Journal:  Behav Brain Res       Date:  2008-05-16       Impact factor: 3.332

Review 5.  The dynamic effects of nicotine on the developing brain.

Authors:  Jennifer B Dwyer; Susan C McQuown; Frances M Leslie
Journal:  Pharmacol Ther       Date:  2009-03-05       Impact factor: 12.310

Review 6.  Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.

Authors:  J Zhu; M E A Reith
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

7.  GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs.

Authors:  Daniela Marazziti; Silvia Mandillo; Chiara Di Pietro; Elisabetta Golini; Rafaele Matteoni; Glauco P Tocchini-Valentini
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-22       Impact factor: 11.205

8.  Cortical excitability in smoking and not smoking individuals with and without nicotine.

Authors:  J Grundey; S Freznosa; F Klinker; N Lang; W Paulus; M A Nitsche
Journal:  Psychopharmacology (Berl)       Date:  2013-05-05       Impact factor: 4.530

Review 9.  Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction.

Authors:  Yann S Mineur; Marina R Picciotto
Journal:  Biochem Pharmacol       Date:  2007-06-14       Impact factor: 5.858

10.  Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder.

Authors:  J Lee; N Laurin; J Crosbie; A Ickowicz; T Pathare; M Malone; J L Kennedy; R Tannock; R Schachar; C L Barr
Journal:  Genes Brain Behav       Date:  2007-05-14       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.